PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal degeneration

Journal of the Neurological Sciences

Volumn 139, Issue 2, 1996, Pages 210-217

  Nagasawa, Haruo ^a,b   Tanji, Hiroaki ^b   Nomura, Hiroshi ^b   Saito, Hiroshi ^b   Itoyama, Yasuto ^b   Kimura, Itaru ^a   Tuji, Shoji ^d   Fujiwara, Takehiko ^c   Iwata, Ren ^c   Itoh, Masatoshi ^c   Tatsuo, Ido ^c  

^a MIYAGI NATIONAL HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

^d NIIGATA UNIVERSITY   (Japan)

Author keywords

Cerebral metabolic rate of glucose; Corticobasal degeneration; Dopamine metabolism; Positron emission tomography

Indexed keywords

FLUORINE 18; FLUORODOPA F 18; LEVODOPA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN DEGENERATION; CATECHOLAMINE METABOLISM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0030218927     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(96)00057-3     Document Type: Article

References (27)

1. Adam, M.J., B. Abeysekera, T.J. Ruth, J.R. Grierson and B.D. Pate (1985) Synthesis of 6-(F-18)L-fluorodopa using F-18 labelled acetylhypofluorite. J. Nucl. Med., 26: 125.
2. Blin, J., M.J. Vidailhet, B. Pillon, B. Dubois, J.R. Feve and Y. Agid (1991) Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET. Mov. Dis., 7: 348-354.
3. 18F-fluoro-deoxyglucose and positron emission tomography. Neurology. 164 (suppl 1): 164.
4. Ferris, S.H., M.J. DeLeon, A.P. Wolf, T. Farkas, D.R. Christman, B. Reisberg, J.S. Fowler, R. MacGregor, A. Goldman, A.E. George and S. Rampal (1981) Positron emission tomography in the study of aging and senile dementia. Neurobiol. Aging, 1: 127-131.
5. Frackowiak, R.S.J., C. Pozzilli, N.J. Legg, G.H. DuBoulay, J. Marshall, G.L. Lenzi and T. Jones (1981) Regional cerebral oxygen supply and utilization in dementia: a clinical and physiological study with oxygen-15 and positron emission tomography. Brain, 104: 753-778.
6. 18F]fluorodeoxy-glucose. J. Comput. Assist Tomogr., 7: 590-598.
7. Gibb, W.R.G., P.J. Luthert and C.D. Marsden (1989) Corticobasal degeneration. Brain, 112: 1171-1192.
8. Huang, S.C., M.E. Phelps, E.J. Huffman, K. Sideris, C.J. Selin and D.E. Kuhl (1980) Noninvasive determination of local cerebral metabolic rate of glucose in man. Am. J. Physiol., 238: E69-E82.
9. Kuhl, D.E., E.J. Metter, W.H. Riege and C.H. Markham (1984a) Patterns of cerebral glucose utilization in Parkinson's disease and Huntinglon's disease. Ann. Neurol., 15 (Suppl.): S119-S125.
10. 18F]fluorodeoxyglucose method. Ann. Neurol., 15: 419-424.
11. Leenders, K.L., A.J. Palmer, N. Quinn, J.C. Clark, G. Firnau, E.S. Garnett, C. Nahmias, T. Jones and C.D. Marsden (1986) Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography. J. Neurol. Neurosurg. Psychiatr., 49: 853-860.
12. Martin, W.R.W., J.H. Beckman, D.B. Calne, M.J. Adam, R. Harrop, J.G. Rogers, T.J. Ruth, C.I. Sayre and B.D. Pate (1984) Cerebral glucose metabolism in Parkinson's disease. Can. J. Neurol. Sci., 11: 169-173.
13. Nagasawa, H., T. Imamura, H. Nomura, M. Itoh and T. Ido (1993a) A case of corticobasal degeneration studied with positron emission tomography. Behav. Neurol., 6: 59-64.
14. 18F]fluorodopa metabolism in patients with hemiparkinsonisrn studied by positron emission tomography. J. Neurol. Sci., 115: 136-143.
15. Nagasawa, H., K. Kogure, T. Fujiwara, M. Itoh and T. Ido (1994a) Metabolic disturbances in exo-focal brain areas after cortical stroke studied by positron emission tomography. J. Neurol. Sci., 123: 147-153.
16. 18FDG and positron emission tomography. NeuroReport, 5: 961-964.
17. Patlak, C.S., R.G. Blasberg and J.D. Fenstermacher (1983) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood Flow Metab., 3: 1-7.
18. Patlak, C.S. and R.G. Blasberg (1985) Graphical evaluation of blood-to-brain transfer constants from multiple time uptake data. generalizations. J. Cereb. Blood Flow Metab., 5: 584-590.
19. Phelps, M.E., S.C. Huang, E.J. Hoffman, C. Selin, L. Sokoloff and D.E. Kuhl (1979) Tomographic measurement of local cerebral glucose metabolic rate in human with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann. Neurol., 6: 371-388.
20. Rebeiz, J.J., E.H. Kolodny and E.P. Richardson (1986) Corticodentatonigral degeneration with neuronal achromasia. Arch. Neurol., 18: 20-33.
21. Riley, D.E., A.E. Lang, A. Lewis, L. Resch, P. Ashby, O. Hornykiewicz and S. Black (1990) Corticobasal ganglionic degeneration. Neurology 40: 1203-1212.
22. Rougemont, D., J.C. Baron, P. Collard, P. Bustany, D. Comar and Y. Agid (1984) Local cerebral glucose utilization in treated and untreated patients with Parkinson's disease. J. Neurol. Neurosurg. Psychiatr., 47: 824-830.
23. Salamon, G. and Y.P. Huang (1980) Computed Tomography of the Brain. Springer-Verlag, Berlin, Heidelberg, New York.
24. Sawle, G.V., D.J. Brooks, C.D. Marsden and R.S.J. Frackowiak (1991) Corticobasal degeneration. A unique pattern of regional cortical oxygen hypometabolism and straital fluorodopa uptake demonstrated by positron emission tomography. Brain, 114: 541-556.
25. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem., 28: 897-916.
26. Talairach, J. and P. Tournoux (1988) Co-planar sterotaxic atlas of the human brain. 3-dimensional proportional system: an approach to cerebral imaging. Georg Thieme Verlag, Stuttgart.
27. Watts, R.L., R.S. Williams, J.D. Growdon, R.R. Young, E.C. Haley and M.F. Beal (1985) Corticobasal ganglionic degeneration. Neurology 35 (Suppl. 1): 178 (Abstract).